Bal Pharma reports standalone net loss of Rs 4.14 crore in the March 2020 quarter

Sales decline 39.92% to Rs 33.77 crore

Net loss of Bal Pharma reported to Rs 4.14 crore in the quarter ended March 2020 as against net profit of Rs 3.57 crore during the previous quarter ended March 2019. Sales declined 39.92% to Rs 33.77 crore in the quarter ended March 2020 as against Rs 56.21 crore during the previous quarter ended March 2019.

For the full year,net loss reported to Rs 9.53 crore in the year ended March 2020 as against net profit of Rs 6.76 crore during the previous year ended March 2019. Sales declined 23.49% to Rs 170.67 crore in the year ended March 2020 as against Rs 223.08 crore during the previous year ended March 2019.

ParticularsQuarter EndedYear EndedMar. 2020Mar. 2019% Var.Mar. 2020Mar. 2019% Var.Sales33.7756.21 -40 170.67223.08 -23 OPM %2.3411.87 -3.679.10 - PBDT-0.583.84 PL -2.5410.53 PL PBT-3.611.47 PL -9.574.41 PL NP-4.143.57 PL -9.536.76 PL

Powered by Capital Market - Live News